Sensory Examination Tool for Clinicians – Printable handouts for speech, occupational, and physical therapists
Pharmaceutics | Free Full-Text | Novel Therapeutic Approaches in Inherited Neuropathies: A Systematic Review
Overall Neuropathy Limitations Scale (ONLS) - Neurology - CaptureProof
FDA Clears Device for Pain Related to Diabetic Peripheral Neuropathy
ONLS - "Overall Neuropathy Limitations Scale" by AcronymsAndSlang.com
Frontiers | Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A
The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury: 2021 update | Spinal Cord
View Image
Charcot-Marie-Tooth Disease - Pharnext unveils the latest progress of the PREMIER Phase III clinical trial for CMT1A
Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy | Neurology and Therapy
Optimizing the Use of Outcome Measures in Chronic Inflammatory Demyelinating Polyneuropathy - touchNEUROLOGY
A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment | Orphanet Journal of Rare Diseases
Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study - The Lancet Neurology
![PDF] Clinical heterogeneity, diagnostic features, outcomes of Guillain-Barré syndrome spectrum disorders: an analysis of IGOS UK data | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ea24df1310dd756ba89e6fcbf10dec8bcf2e6818/52-Figure1.4-1.png "PDF] Clinical heterogeneity, diagnostic features, outcomes of Guillain-Barré syndrome spectrum disorders: an analysis of IGOS UK data | Semantic Scholar")
PDF] Clinical heterogeneity, diagnostic features, outcomes of Guillain-Barré syndrome spectrum disorders: an analysis of IGOS UK data | Semantic Scholar
A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A | Orphanet Journal of Rare Diseases | Full Text
Corporate presentation
Echelles d'handicap : MIDAS, ONLS, mRS - ppt télécharger
A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. - Abstract - Europe PMC
Gluten neuropathy: prevalence of neuropathic pain and the role of gluten-free diet
Table 4 from Residual disability 10years after falling ill in Guillain–Barré syndrome: A prospective follow-up study | Semantic Scholar
PDF) A modified peripheral neuropathy scale: The Overall Neuropathy Limitations Scale
Clinimetric properties of a walking scale in peripheral neuropathy | Journal of Neurology, Neurosurgery & Psychiatry
Trial design and outcomes for inherited neuropathy studies D. Pareyson IRCCS Foundation C.Besta Neurological Institute Milan, Italy MSG Meeting, Buffalo, - ppt download
Overall Neuropathy Limitations Scale (ONLS) - Neurology - CaptureProof
